... POTOMAC FALLS Va. April 25 2013 /PRNewswi...The agreement solidifies a development partnership which allows Kindst...Kindstar Founder and CEO Dr. Shiang Huang Tom Richards TessArae President an...
POTOMAC FALLS, Va., April 25, 2013 /PRNewswire/ --?TessArae?, LLC and Kindstar Global, the largest esoteric reference laboratory in China, have signed a collaboration agreement for the development of a pan-ethnic carrier screen for the Chinese population.? The assay, which will be run in Kindstar's laboratories in China, employs TessArae's targeted sequencing development platform and proprietary bioanalysis software.?
The agreement solidifies a development partnership which allows Kindstar to leverage TessArae's design expertise to create and market its own Laboratory Developed Test (LDT) specific to the Chinese market.? TessArae's development platform combines a highly multiplexed amplification strategy with a standard Affymetrix microarray protocol.? Results are delivered as genomic sequence, automatically generated and analyzed by TessArae's GeneCipher? algorithms.
Kindstar Founder and CEO, Dr. Shiang Huang said in a statement, "TessArae's development platform is a unique and valuable tool that provides Kindstar near immediate access to key markets with clinically appropriate, sequence-driven diagnostics. ??Kindstar is able to capture revenue faster at less cost by partnering with TessArae in the expansion of our test menu."
Dr. Tom Richards , TessArae President and CEO, commented "TessArae's development platform grants our partners the combined benefits of two worlds: the efficiency and predictability of microarrays with the rich specificity of genetic sequencing.? As a result, they can develop market-specific genetics assays much more quickly than alternative approaches.? We are excited to partner with Kindstar in bringing their vision of recessive disease testing to the Chinese market."
Kindstar provides esoteric diagnostic testing serv
'/>"/>
Related biology technology :
1. Chinese Scientists Zhen-Yi Wang and Zhu Chen Awarded 7th Annual Szent-Gyorgyi Prize for Progress in Cancer Research
2. NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents
3. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
4. MRIGlobal, DHMRI Align in Strategic Collaboration
5. - Unigene Secures Financing to Extend Operating Runway in Conjunction with Strategic Reorganization -
6. VG Life Sciences, Inc. Secures Two-Year Funding Commitment and Administrative Support from MedBridge, LLC
7. Nabsys Secures $20 Million Series D Financing to Support Launch of Semiconductor-Based Single-Molecule Platform for Genomic Analysis
8. Unisense FertiliTech A/S Secures an Additional 20 Million USD in New Capital Investment
9. lifeIMAGE Announces No-Cost Service for Hospitals to Give Patients Secure Access to Medical Imaging, Pledges Support for the Blue Button Initiative
10. Blue Marble Biomaterials Secures Distribution Agreement with SAFC
11. Turning smartphones into secure and versatile keys
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.